92 related articles for article (PubMed ID: 3768871)
21. Human autopsy tissue distribution of the epipodophyllotoxins etoposide and teniposide.
Stewart DJ; Grewaal D; Redmond MD; Mikhael NZ; Montpetit VA; Goel R; Green RM
Cancer Chemother Pharmacol; 1993; 32(5):368-72. PubMed ID: 8339387
[TBL] [Abstract][Full Text] [Related]
22. Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells.
Shipp NG; Dorr RT; Alberts DS; Dawson BV; Hendrix M
Cancer Res; 1993 Feb; 53(3):550-6. PubMed ID: 8425187
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive and nondestructive optical spectroscopic measurement of motexafin gadolinium in mouse tissues: comparison to high-performance liquid chromatography.
Kanick SC; Eiseman JL; Joseph E; Guo J; Parker RS
J Photochem Photobiol B; 2007 Sep; 88(2-3):90-104. PubMed ID: 17604637
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and metabolism of mitoxantrone. A review.
Ehninger G; Schuler U; Proksch B; Zeller KP; Blanz J
Clin Pharmacokinet; 1990 May; 18(5):365-80. PubMed ID: 2185907
[TBL] [Abstract][Full Text] [Related]
25. Tissue distribution of amiodarone and desethylamiodarone in rats after repeated oral administration of various amiodarone dosages.
Plomp TA; Wiersinga WM; Maes RA
Arzneimittelforschung; 1985; 35(12):1805-10. PubMed ID: 4096733
[TBL] [Abstract][Full Text] [Related]
26. The dynamics of concentration of the main fluorescent component of Ukrain in the tissues and blood plasma of rats with W-256 tumor after a single intravenous injection.
Doroshenko YM; Karavay AV; Hodysh YY; Uglyanitsa KN; Nowicky WM; Nefyodov LI
Drugs Exp Clin Res; 2000; 26(5-6):171-7. PubMed ID: 11345024
[TBL] [Abstract][Full Text] [Related]
27. High-dose mitoxantrone and cyclophosphamide without stem cell support in high-risk and advanced solid tumors: a phase I trial.
Pérez-Gracia JL; Colomer R; Ruiz-Casado A; Arcediano A; Tornamira MV; Gómez-Martin C; Valentin V; Mendiola C; Cortés-Funes H; Hornedo J
Bone Marrow Transplant; 2001 Jan; 27(2):117-23. PubMed ID: 11281378
[TBL] [Abstract][Full Text] [Related]
28. NTP Toxicology and Carcinogenesis Studies of Nitrofurazone (CAS No. 59-87-0) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1988 Jun; 337():1-183. PubMed ID: 12732899
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the myocardial performance index for early detection of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis.
Pattoneri P; Pelà G; Montanari E; Pesci I; Moruzzi P; Borghetti A
Eur J Echocardiogr; 2007 Mar; 8(2):144-50. PubMed ID: 16603413
[TBL] [Abstract][Full Text] [Related]
30. Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors.
Lim HJ; Masin D; McIntosh NL; Madden TD; Bally MB
J Pharmacol Exp Ther; 2000 Jan; 292(1):337-45. PubMed ID: 10604968
[TBL] [Abstract][Full Text] [Related]
31. Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity.
Adlakha-Hutcheon G; Bally MB; Shew CR; Madden TD
Nat Biotechnol; 1999 Aug; 17(8):775-9. PubMed ID: 10429242
[TBL] [Abstract][Full Text] [Related]
32. A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer.
Chi KN; Gleave ME; Klasa R; Murray N; Bryce C; Lopes de Menezes DE; D'Aloisio S; Tolcher AW
Clin Cancer Res; 2001 Dec; 7(12):3920-7. PubMed ID: 11751483
[TBL] [Abstract][Full Text] [Related]
33. Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1992 Mar; 407():1-289. PubMed ID: 12621523
[TBL] [Abstract][Full Text] [Related]
34. Human autopsy-tissue distribution of menogaril and its metabolites.
Stewart DJ; Grewaal D; Green RM; Goel R; Mikhael N; Montpetit VA; Redmond D; Earhart R
Cancer Chemother Pharmacol; 1993; 32(5):373-8. PubMed ID: 8339388
[TBL] [Abstract][Full Text] [Related]
35. NTP Toxicology and Carcinogenesis Studies of Nitrofurantoin (CAS No. 67-20-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Sep; 341():1-218. PubMed ID: 12724784
[TBL] [Abstract][Full Text] [Related]
36. Colchicine poisoning: report of a fatal case with body fluid and post-mortem tissue analysis by high-performance liquid chromatography.
Dehon B; Chagnon JL; Vinner E; Pommery J; Mathieu D; Lhermitte M
Biomed Chromatogr; 1999 May; 13(3):235-8. PubMed ID: 10375125
[TBL] [Abstract][Full Text] [Related]
37. Phase I study of a 5-day schedule of mitoxantrone (dihydroxyanthracenedione).
Wynert WR; Harvey HA; Lipton A; Schweitzer J; White DS
Cancer Treat Rep; 1982 Jun; 66(6):1303-6. PubMed ID: 7083234
[TBL] [Abstract][Full Text] [Related]
38. Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors.
Ogilvie GK; Moore AS; Obradovich JE; Elmslie RE; Vail DM; Straw RC; Salmon MD; Klein MK; Atwater SW; Ciekot PE
J Am Vet Med Assoc; 1993 Jun; 202(11):1839-44. PubMed ID: 8320152
[TBL] [Abstract][Full Text] [Related]
39. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
40. Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion.
Vogelsinger H; Weiler S; Djanani A; Kountchev J; Bellmann-Weiler R; Wiedermann CJ; Bellmann R
J Antimicrob Chemother; 2006 Jun; 57(6):1153-60. PubMed ID: 16627591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
